Opportunities for Harold Hamm Diabetes Center members include funding awards
and access to
core facilities. Several types of funding awards are available to members to support the
development of their work. Award applications are evaluated on a competitive,
peer-reviewed basis by the Harold Hamm Research Grants Committee and External
Review Panel. Additional awards, such as matching awards to other funding
opportunities, will be announced if they become available.
2026 Award Opportunities
Funding Opportunity Summary
The Harold Hamm Diabetes Center (HHDC) is pleased to announce pilot funding
opportunities for 2026. The HHDC Pilot Program will consider funding for
the following types of funding: I2 Accelerator, Team Science, Novel Pilot
(Faculty and Post-Doc tracks), Bridge Funding, and Equipment Grants. Based
on a matching gift, the HHDC will award up to $2.5M to researchers to
launch investigations for diabetes research. For projects that feature
collaboration between researchers of Diabetes and Cancer, the Stephenson
Cancer Center has the potential to augment funding.
Key Information
HHDC Funded Programs:
I2 Accelerator Grant: $300,000 for up to 2 years
Team Science Grant: $100,000 per year for up to 3 years
Novel Pilot Grant (Faculty and Post-Doc tracks): $70,000 per year for up
to 2 years
Bridge Grant: $100,000 for 1 year
Equipment Grant: Up to $250,000
HHDC-SCC Funded Programs:
Team Science Grant: $100,000 per year for up to 3 years
Novel Pilot Grant (Faculty or Post-Doc tracks): $70,000 per year for up
to 2 years
Funding Priorities:
Applications should be closely aligned with the mission of the HHDC to
increase understanding about the causes and consequences of diabetes and
closely related cardiometabolic conditions like obesity, liver disease,
and cancer (HHDC-SCC proposals), as well as strategies for prevention
or treatment of these conditions. The goal of all HHDC funding projects
should be to support the development of successful extramural grants from
the NIH (e.g. NIDDK grants will be given priority), American Diabetes
Association, Breakthrough T1D, etc.
Proposals that address one or more of the following themes are HHDC funding
priorities:
Theme 1: Diabetes and Obesity, origins within the first 1000 days of life
or changes across the lifespan. These are proposals that aim to gain basic science and clinical knowledge
on the inter-relationship of obesity and diabetes during fetal development
and early life, or across the lifespan. For example, we are interested
in studies of the genetic, epigenetic, and environmental basis of susceptibility
to developing insulin resistance, metabolic dysregulation, inflammation,
macrovascular and microvascular diabetic complications, obesity, and diabetes.
This includes studies of type 1, type 2, and gestational diabetes, and
pre-diabetes.
Theme 2: Complications from diabetes and related metabolic disease. Proposals in this area examine how diabetes, obesity, or complications
thereof result in increased morbidity and mortality. Translational research
focused on basic mechanisms of disease in pre-clinical models of obesity/diabetes
are acceptable.
Theme 3: Clinical Research/Public Health. We seek proposals to investigate new treatments, interventions, and technology
for diabetes management, along with strategies to raise awareness, promote
prevention, or improve diabetes care. Proposals that address health disparities
related to diabetes, and early-stage clinical investigators are particularly
encouraged.
Theme 4: Diabetes/Obesity and Cancer. Proposals in this area examine how diabetes or obesity affect the risk
or treatment of cancer. Proposals may include basic and/or clinical models.
Team science and novel pilot projects in this area are jointly supported
by HHDC and Stephenson Cancer Center.
The emphasis of the HHDC pilot program is to provide foundational support
that will permit investigators to compete successfully for extramural
sources of research support such as the NIH, American Diabetes Association,
JDRF, etc. Projects without evidence of potential for generating external
funding will be given lower priority scores during evaluation.
Eligibility
The PI and/or MPI of any HHDC grant application must be an active HHDC
Member or Associate Member at the time the Letter of Intent is submitted.
The Co-Investigators do not have to be members at the time of application,
but if successful are encouraged to become Members or Associate Members
of the HHDC during the tenure of the grant. Active HHDC PIs/MPIs may not
apply as PI/MPI for a new Novel, Bridge, I2 Accelerator, or Team Science
Grant. The PI/MPI of new grant proposals may maintain roles as Co-Investigators
(Co-Is) on active HHDC-supported grants.
Application Process
Letter of Intent
Letters of Intent are due to
HHDCGrants@ouhsc.edu by
5 p.m. on Wednesday, Jan. 14, 2026. Applicants with LOI proposals that fit the HHDC mission and have potential
for success will be invited to submit a full application in March. All
LOI applicants will be notified about the status of their proposal by
Feb. 6, 2026.
Please see the templates below for grant-specific submission requirements.
Full Application
Application requirements and attachments will vary by proposal type. Please
see grant specific guidelines below for further information.
In accordance with OUHSC policy, a SoonerTrack routing form should be submitted
at least three to five full business days prior to the March 11, 2026 grant
application deadline. Applicants are expected to work with their assigned Sponsored Program
Administrator (SPA) for review of the application.
Once the review is complete, the Face Page of the application must be signed
by the ORA Official (or equivalent signing official at institutions other
than OUHSC) before the PI submits the final application to HHDC.
Please note: HHDC will e-mail PIs with projects eligible for second- or
third-year renewals with details on renewal application processes. For
questions, please reach out directly to
HHDCgrants@ouhsc.edu
Review of Final Application
The HHDC Grants Review Committee will review and award grants in consultation
with two outside reviewers and one internal reviewer. Outside reviewers
will be selected for each application based on their relevant subject
matter expertise. Once appointed, the HHDC Grants Review Committee and
panel of outside reviewers will evaluate the proposal to come to a funding decision.
Program Application and Deadlines
All applications will follow the HHDC Application Form, Terms and Guidelines
found below.
*Please note that the Pilot Grant RFA/guidelines have been updated for
2026. Please refer to the guidelines below for the most current version.
HHDC Pilot Grant Guidelines: (Grants with the potential for SCC collaborative
funding denoted by “*”)
Diabetes & EndocrinologyOklahoma City, OKView Profile
4.9 out of 5
.png)
